Lovastatin increases exercise-induced skeletal muscle injury☆
References (27)
- et al.
Lovastatin and elevated creatine kinase: Results of rechallenge
Lancet
(1989) - et al.
The effects of exercise and lovastatin on serum creatine kinase activity
Metabolism
(1991) - et al.
Lovastatin, isoprenes, and myopathy
Lancet
(1989) - et al.
Long-term safety and efficacy profile of simvastatin
Am J Cardiol
(1991) - et al.
Effects of treadmill exercise on total and myocardial creatine phosphokinase
Chest
(1981) - et al.
The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle
Am J Cardiol
(1996) - et al.
Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome
Am J Med
(1993) - et al.
Protective effect of coenzyme Q10 on exercise-induced muscle injury
Biochem Biophys Res Commun
(1991) - et al.
Massive rhabdomyolysis and simvastatin
Clin Chem
(1992) - et al.
Rhabdomyolysis and renal injury with lovastatin use
JAMA
(1988)
Lovastatin, nicotinic acid and rhabdomyolsis
Ann Intern Med
(1988)
Lovastatin and rhabdomyolysis
Ann Intern Med
(1988)
Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation
N Engl J Med
(1988)
Cited by (152)
Prolonged Moderate-Intensity Exercise Does Not Increase Muscle Injury Markers in Symptomatic or Asymptomatic Statin Users
2023, Journal of the American College of CardiologySuccessful treatment of a patient with mitochondrial myopathy with alirocumab
2020, Journal of Clinical LipidologyA Mechanism for Statin-Induced Susceptibility to Myopathy
2019, JACC: Basic to Translational ScienceProsarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
2018, Trends in Pharmacological SciencesStatins and muscle damage
2018, Nutrition and Skeletal Muscle
- ☆
Supported by grants from Bristol-Myers Squibb Pharmaceutical Division, the Hethea and Richard Nye Foundation, the Haire Family, William Jakober, and the McNulty Family.
Copyright © 1997 Published by Elsevier Inc.